Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene ...
The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback